| Medical and Health Sciences | Lifetime | 983 | IT 29 | 99.95 |
| Medical and Health Sciences | 2021-2025 | 160 | IT 14 | 99.97 |
| Epidemiology | Lifetime | 149 | IT 5 | 99.80 |
| Infectious Diseases | Lifetime | 195 | IT 10 | 99.32 |
| Microbiology | Lifetime | 60 | IT 2 | 99.13 |
| Emergency Medical Services | Lifetime | 119 | IT 3 | 98.73 |
| Pulmonary and Respiratory Medicine | Lifetime | 607 | IT 26 | 99.12 |
| Public, Environmental and Occupational Health | Lifetime | 847 | IT 13 | 98.78 |
| Health | Lifetime | 579 | IT 6 | 95.96 |
| Otolaryngology | Lifetime | 368 | IT 13 | 93.98 |
| Critical Care and Intensive Care Medicine | Lifetime | 554 | IT 21 | 84.02 |
| Gastroenterology | Lifetime | 675 | IT 42 | 76.86 |
| Epidemiology | 2021-2025 | 37 | IT 3 | 99.79 |
| Infectious Diseases | 2021-2025 | 66 | IT 8 | 99.01 |
| Surgery | 2021-2025 | 214 | IT 15 | 98.72 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 172 | IT 13 | 98.72 |
| Public, Environmental and Occupational Health | 2021-2025 | 281 | IT 11 | 97.62 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 229 | IT 7 | 95.45 |
| Clinical Neurology | 2021-2025 | 200 | IT 18 | 94.50 |
| Clinical Psychology | 2021-2025 | 651 | IT 11 | 93.23 |
| Obstetrics and Gynecology | 2021-2025 | 228 | IT 16 | 91.13 |
| Medical Physiology | 2021-2025 | 676 | IT 31 | 89.34 |
| Pneumonia and Respiratory Infections | Lifetime | 20 | IT 1 | 99.82 |
| Respiratory viral infections research | Lifetime | 34 | IT 1 | 99.80 |
| Bacterial Infections and Vaccines | Lifetime | 24 | IT 2 | 99.61 |
| Influenza Virus Research Studies | Lifetime | 58 | IT 2 | 99.60 |
| Pediatric health and respiratory diseases | Lifetime | 48 | IT 3 | 99.52 |
| Vaccine Coverage and Hesitancy | Lifetime | 55 | IT 2 | 99.27 |
| Viral gastroenteritis research and epidemiology | Lifetime | 140 | IT 4 | 99.41 |
| COVID-19 Clinical Research Studies | Lifetime | 197 | IT 21 | 99.02 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 220 | IT 5 | 99.10 |
| Streptococcal Infections and Treatments | Lifetime | 93 | IT 1 | 99.26 |
| Viral Infections and Immunology Research | Lifetime | 128 | IT 7 | 98.94 |
| Long-Term Effects of COVID-19 | Lifetime | 161 | IT 25 | 98.35 |
| Tracheal and airway disorders | Lifetime | 254 | IT 10 | 98.94 |
| COVID-19 and Mental Health | Lifetime | 209 | IT 13 | 97.94 |
| Infectious Diseases and Tuberculosis | Lifetime | 131 | IT 7 | 98.64 |
| Kawasaki Disease and Coronary Complications | Lifetime | 45 | IT 5 | 98.42 |
| COVID-19 Impact on Reproduction | Lifetime | 61 | IT 7 | 98.00 |
| Respiratory and Cough-Related Research | Lifetime | 135 | IT 8 | 99.11 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 41 | IT 3 | 98.15 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 252 | IT 14 | 98.51 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 336 | IT 12 | 98.33 |
| Neonatal and Maternal Infections | Lifetime | 97 | IT 3 | 98.07 |
| Neonatal Respiratory Health Research | Lifetime | 736 | IT 19 | 98.19 |
| Sepsis Diagnosis and Treatment | Lifetime | 568 | IT 18 | 97.58 |
| Hematological disorders and diagnostics | Lifetime | 275 | IT 15 | 96.07 |
| Infant Health and Development | Lifetime | 223 | IT 7 | 96.65 |
| Otolaryngology and Infectious Diseases | Lifetime | 88 | IT 2 | 95.87 |
| Parvovirus B19 Infection Studies | Lifetime | 284 | IT 17 | 96.92 |
| Cystic Fibrosis Research Advances | Lifetime | 423 | IT 14 | 96.72 |
| Diabetes and associated disorders | Lifetime | 980 | IT 45 | 96.75 |
| Sinusitis and nasal conditions | Lifetime | 356 | IT 23 | 96.61 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 756 | IT 20 | 96.94 |
| Pharmaceutical studies and practices | Lifetime | 777 | IT 19 | 95.26 |
| COVID-19 epidemiological studies | Lifetime | 876 | IT 27 | 95.11 |
| Inflammasome and immune disorders | Lifetime | 732 | IT 49 | 94.17 |
| Vitamin D Research Studies | Lifetime | 818 | IT 29 | 95.10 |
| Coronary Artery Anomalies | Lifetime | 570 | IT 23 | 95.20 |
| Ear Surgery and Otitis Media | Lifetime | 570 | IT 20 | 95.33 |
| Peripheral Neuropathies and Disorders | Lifetime | 811 | IT 81 | 94.62 |
| Immune responses and vaccinations | Lifetime | 733 | IT 22 | 83.89 |
| Congenital limb and hand anomalies | Lifetime | 942 | IT 28 | 73.65 |
| Bartonella species infections research | Lifetime | 699 | IT 25 | 71.69 |
| Lymphadenopathy Diagnosis and Analysis | Lifetime | 222 | IT 31 | 63.17 |
| Pneumonia and Respiratory Infections | 2021-2025 | 9 | IT 2 | 99.39 |
| Neonatal Respiratory Health Research | 2021-2025 | 17 | IT 2 | 99.38 |
| Respiratory viral infections research | 2021-2025 | 16 | IT 1 | 99.54 |
| COVID-19 Impact on Reproduction | 2021-2025 | 20 | IT 1 | 98.67 |
| COVID-19 Clinical Research Studies | 2021-2025 | 194 | IT 15 | 98.97 |
| Long-Term Effects of COVID-19 | 2021-2025 | 125 | IT 14 | 98.43 |
| Kawasaki Disease and Coronary Complications | 2021-2025 | 17 | IT 2 | 98.00 |
| Tracheal and airway disorders | 2021-2025 | 73 | IT 8 | 97.49 |
| Streptococcal Infections and Treatments | 2021-2025 | 34 | IT 2 | 97.15 |
| Neonatal and Maternal Infections | 2021-2025 | 20 | IT 2 | 96.37 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 651 | IT 34 | 97.42 |
| Pediatric health and respiratory diseases | 2021-2025 | 51 | IT 5 | 96.47 |
| COVID-19 and Mental Health | 2021-2025 | 450 | IT 32 | 96.01 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 82 | IT 5 | 95.06 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 406 | IT 23 | 94.88 |
| Cystic Fibrosis Research Advances | 2021-2025 | 167 | IT 19 | 95.54 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 451 | IT 34 | 93.40 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 569 | IT 30 | 91.76 |
| Neutropenia and Cancer Infections | 2021-2025 | 163 | IT 18 | 89.04 |
| Surgical site infection prevention | 2021-2025 | 129 | IT 5 | 88.13 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 328 | IT 38 | 90.93 |
| Diabetes and associated disorders | 2021-2025 | 509 | IT 41 | 90.73 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 754 | IT 26 | 90.08 |
| Infectious Diseases and Tuberculosis | 2021-2025 | 219 | IT 8 | 87.91 |
| Infant Health and Development | 2021-2025 | 127 | IT 5 | 84.93 |
| Mobile Health and mHealth Applications | 2021-2025 | 830 | IT 11 | 84.44 |
| Respiratory and Cough-Related Research | 2021-2025 | 450 | IT 61 | 86.29 |
| Congenital Diaphragmatic Hernia Studies | 2021-2025 | 611 | IT 47 | 83.53 |
| Herpesvirus Infections and Treatments | 2021-2025 | 661 | IT 36 | 81.56 |
| Antimicrobial Resistance in Staphylococcus | 2021-2025 | 752 | IT 40 | 82.65 |
| Coronary Artery Anomalies | 2021-2025 | 384 | IT 36 | 79.51 |
| Urinary Tract Infections Management | 2021-2025 | 756 | IT 44 | 78.38 |
| Neonatal and fetal brain pathology | 2021-2025 | 955 | IT 43 | 80.39 |
| Ultrasound in Clinical Applications | 2021-2025 | 722 | IT 103 | 77.93 |
| Pharmaceutical studies and practices | 2021-2025 | 699 | IT 45 | 78.36 |
| Pediatric Urology and Nephrology Studies | 2021-2025 | 838 | IT 92 | 79.11 |
| Otolaryngology and Infectious Diseases | 2021-2025 | 105 | IT 3 | 74.84 |
| Pleural and Pulmonary Diseases | 2021-2025 | 823 | IT 104 | 73.33 |
| Bacterial Infections and Vaccines | 2021-2025 | 796 | IT 38 | 72.74 |
| Oral health in cancer treatment | 2021-2025 | 568 | IT 45 | 66.32 |
| Healthcare Systems and Technology | 2021-2025 | 514 | IT 1 | 64.09 |
| Diagnosis and treatment of tuberculosis | 2021-2025 | 915 | IT 33 | 62.51 |
| Infections and bacterial resistance | 2021-2025 | 370 | IT 26 | 52.97 |